(Q42592824)

English

Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo

scientific article published on 30 May 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo (English)

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

multiple myeloma

1 reference

based on heuristic

inferred from title

author name string

A Olivieri

1

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

M Marchetti

2

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

R Lemoli

3

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

C Tarella

4

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

A Iacone

5

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

F Lanza

6

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

A Rambaldi

7

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

A Bosi

8

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Italian Group for Stem Cell Transplantation

9

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

language of work or name

0 references

publication date

30 May 2011

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

47

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

3

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

342-351

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

How to treat a newly diagnosed young patient with multiple myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Current treatment standards and emerging strategies in mantle cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Controversies in the treatment of lymphoma with autologous transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Therapeutic options in relapsed or refractory diffuse large B-cell lymphoma. Part 2. Novel therapeutic strategies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Role of hematopoietic stem cell transplant in the management of follicular lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Improving stem cell mobilization strategies: future directions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Management strategies for poor peripheral blood stem cell mobilization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Blood stem cell mobilization and collection in patients with lymphoproliferative diseases: practical issues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Current treatment strategies for multiple myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

What is the optimum number of CD34+ peripheral blood stem cells for an autologous transplant?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Good and poor CD34+ cells mobilization in acute leukemia: analysis of factors affecting the yield of progenitor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

The whys and hows of hematopoietic progenitor and stem cell mobilization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

CD34(+) cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Mobilization of hematopoietic stem cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential GM-CSF/G-CSF in non-Hodgkin's lymphoma patients: a randomized prospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Using at least 5x10(6)/kg CD34+ cells for autologous stem cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

The role of autologous hematopoietic stem cell transplantation in multiple myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphom

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Qualitative Research: Consensus methods for medical and health services research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Defining a Therapeutic Dose of Peripheral Blood Stem Cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

28 May 2018

Successful stem cell remobilization using plerixafor (mozobil) plus granulocyte colony-stimulating factor in patients with non-hodgkin lymphoma: results from the plerixafor NHL phase 3 study rescue protocol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantatio

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Impairment of peripheral blood stem-cell mobilisation in patients with mantle-cell lymphoma following primary treatment with fludarabine and cyclophosphamide +/- rituximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Factors affecting hematopoietic progenitor cell mobilization: an analysis of 307 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

The number of CD34(+) cells in peripheral blood as a predictor of the CD34(+) yield in patients going to autologous stem cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Mobilization of peripheral blood stem cells in CLL patients after front-line fludarabine treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Impaired PBPC collection in patients with myeloma after high-dose melphalan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Fludarabine combination regimen severely affected peripheral blood stem cell mobilization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

The role of diagnosis in patients failing peripheral blood progenitor cell mobilization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Favourable results with a single autologous stem cell transplant following conditioning with busulphan and cyclophosphamide in patients with multiple myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Salvage therapy with an outpatient DHAP schedule followed by PBSC transplantation in 79 lymphoma patients: an intention to mobilize and transplant analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

High CD34+ cell dose promotes faster platelet recovery after autologous stem cell transplantation for acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Optimization of the yield of PBSC for autotransplantation mobilized by high-dose chemotherapy and G-CSF: proposal for a mathematical model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3296914

16 August 2018

Identification of factors associated with poor peripheral blood progenitor cell mobilization in Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall s

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors associated with successful mobilization of progenitor hematopoietic stem cells among patients with lymphoid malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mobilization of peripheral blood stem cells for autologous transplantation patients with hematological malignancies: Influence of disease, mobilization method, age and sex

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Large-volume-apheresis facilitates autologous transplantation of hematopoietic progenitors in poor mobilizer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization and outcome of "hard to mobilize"' lymphoma patients undergoing autologous stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infusion of a high number of CD34+ cells provides a rapid hematopoietic recovery and cost savings in autologous peripheral blood stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient CD34+ cell yield

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mobilization of CD34+ cells in elderly patients (>/= 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is chemotherapy scoring useful to predict progenitor cell mobilisation in patients with non-Hodgkin's lymphoma?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of poor peripheral blood stem cell mobilization: incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of CD34(+) cell dose on resource utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell support

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leuk

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors that influence collection and engraftment of autologous peripheral-blood stem cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilization

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive value of the steady-state peripheral blood progenitor cell (PBPC) counts for the yield of PBPC collected by leukapheresis after mobilization by granulocyte colony-stimulating factor (G-CSF) alone or chemotherapy and G-CSF

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individual stem cell quality in leukapheresis products is related to the number of mobilized stem cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progenitor cell yields are frequently poor in patients with histologically indolent lymphomas especially when mobilized within 6 months of previous chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemopoietic progenitor cell mobilization and harvest following an intensive chemotherapy debulking in indolent lymphoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The predictive value of white cell or CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Timing of platelet recovery is associated with adequacy of leukapheresis product yield after cyclophosphamide and G-CSF in patients with lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral blood progenitor cell (PBPC) counts during steady-state haemopoiesis enable the estimation of the yield of mobilized PBPC after granulocyte colony-stimulating factor supported cytotoxic chemotherapy: an update on 100 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local irradiation prior to stem cell harvest has no influence on CD34+ yield: a quantitative analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625224

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BMT.2011.82

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42592824&oldid=2205517233"